liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes
Hertie Institute Clin Brain Research, Germany German Centre Neurodegenerat Disease, Germany .
Hertie Institute Clin Brain Research, Germany German Centre Neurodegenerat Disease, Germany .
Hertie Institute Clin Brain Research, Germany University of Tubingen, Germany German Centre Neurodegenerat Disease, Germany .
Hertie Institute Clin Brain Research, Germany University of Tubingen, Germany German Centre Neurodegenerat Disease, Germany .
Show others and affiliations
2012 (English)In: American Journal of Pathology, ISSN 0002-9440, E-ISSN 1525-2191, Vol. 181, no 6, 1953-1960 p.Article in journal (Refereed) Published
Abstract [en]

In vivo imaging of pathological protein aggregates provides essential knowledge of the kinetics and implications of these lesions in the progression of proteopathies, such as Alzheimer disease. Luminescent conjugated oligothiophenes are amyloid-specific ligands that bind and spectrally distinguish different types of amyloid aggregates. Herein, we report that heptamer formyl thiophene acetic acid (hFTAA) passes the blood-brain barrier after systemic administration and specifically binds to extracellular beta-amyloid deposits in the brain parenchyma (A beta plaques) and in the vasculature (cerebral beta-amyloid angiopathy) of beta-amyloid precursor protein transgenic APP23 mice. Moreover, peripheral application of hFIAA also stained intracellular lesions of hyperphosphorylated Tau protein in P301S Tau transgenic mice. Spectral profiling of all three amyloid types was acquired ex vivo using two-photon excitation. hFTAA revealed a distinct shift in its emission spectra when bound to A beta plaques versus Tau lesions. Furthermore, a spectral shift was observed for A beta plaques versus cerebral beta-amyloid angiopathy, indicating that different amyloid types and structural variances of a specific amyloid type can be distinguished. In conclusion, by adding spectral signatures to amyloid lesions, our results pave the way for a new area of in vivo amyloid imaging, allowing in vivo differentiation of amyloid (sub)types and monitoring changes of their structure/composition over time. (Am J Pathol 2012, 181: 1953-1960 http://dx.doi.org/10.1016/j.ajpath.2012.08.031)

Place, publisher, year, edition, pages
Elsevier , 2012. Vol. 181, no 6, 1953-1960 p.
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:liu:diva-87202DOI: 10.1016/j.ajpath.2012.08.031ISI: 000311918800009OAI: oai:DiVA.org:liu-87202DiVA: diva2:587461
Available from: 2013-01-14 Created: 2013-01-14 Last updated: 2017-12-06

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Klingstedt, TheréseMason, JeffreyHammarström, PerNilsson, Peter

Search in DiVA

By author/editor
Klingstedt, TheréseMason, JeffreyHammarström, PerNilsson, Peter
By organisation
BiochemistryThe Institute of TechnologyProtein ScienceFaculty of Science & EngineeringOrganic Chemistry
In the same journal
American Journal of Pathology
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 84 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf